Whanin and Lundbeck jointly to launch a novel anti-depressant.

Whanin and Lundbeck Korea have celebrated a joint launching ceremon of Lexapro tab., a new type of anti-depressant at Cheongho Human Resource Development Institute on Jan. 3, distributing the drug in some time January.

Lexapro (Citalopram) exhibits a serotonin dual action with far rapid onset of its effects and better profile of its effects and tolerance than the conventional SSRI anti-dep...